SIBIA Neurosciences (SIBI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (345)	5/14/1999 6:59:00 PM
From: scaram(o)uche	Read Replies (1) of 579

from the new 10-Q, succinct and to the point..... b. Pfizer, Inc. On May 5, 1999, Pfizer, Inc. ("Pfizer") filed an action for declaratory relief against the Company in the United States District Court for the District of Delaware. The complaint purports to seek a judgment regarding the Company's '629 and '128 patents that Pfizer does not infringe and the patents are invalid or unenforceable. The Company's management does not believe that the Pfizer complaint is meritorious and intends to contest that action.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next